We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
(+10%)
Cap. Flow
+$798M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.3M |
| 2 |
Amazon
AMZN
|
+$50M |
| 3 |
Tesla
TSLA
|
+$30.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$26.6M |
| 5 |
EPAM Systems
EPAM
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$39.1M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$31.2M |
| 3 |
XEC
CIMAREX ENERGY CO
XEC
|
+$23.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.54% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
2851
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $184K | ﹤0.01% |
1,773
-9
| -0.5% | -$863 |
|
|
URG
2852
Ur-Energy
URG
$556M
| $183K | ﹤0.01% |
150,305
+26,255
| +21% | +$43K |
|
2853
EverCommerce
EVCM
$1.93B
| $181K | ﹤0.01% |
+11,508
| New | +$205K |
|
2854
CuriosityStream
CURI
$161M
| $180K | ﹤0.01% |
30,414
-869
| -3% | -$7.32K |
|
2855
Lyell Immunopharma
LYEL
$360M
| $180K | ﹤0.01% |
1,165
+321
| +38% | +$71.6K |
|
2856
Vitamin Cottage Natural Grocers
NGVC
$654M
| $180K | ﹤0.01% |
12,655
-465
| -4% | -$5.96K |
|
|
TCRR
2857
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $177K | ﹤0.01% |
38,067
-617
| -2% | -$3.86K |
|
|
MILE
2858
DELISTED
Metromile, Inc. Common Stock
MILE
| $176K | ﹤0.01% |
80,220
+42,871
| +115% | +$122K |
|
|
TBHC
2859
DELISTED
The Brand House Collective
TBHC
| $175K | ﹤0.01% |
11,744
-179
| -2% | -$3.69K |
|
2860
Rimini Street
RMNI
$471M
| $175K | ﹤0.01% |
29,330
-770
| -3% | -$6.05K |
|
2861
Harvard Bioscience
HBIO
$29.2M
| $174K | ﹤0.01% |
2,467
-64
| -3% | -$4.55K |
|
|
NAGE
2862
Niagen Bioscience
NAGE
$247M
| $174K | ﹤0.01% |
46,409
-346
| -0.7% | -$1.87K |
|
|
CSLT
2863
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $173K | ﹤0.01% |
112,045
-888
| -0.8% | -$1.47K |
|
|
WEBR
2864
DELISTED
Weber Inc.
WEBR
| $171K | ﹤0.01% |
13,255
-74
| -0.6% | -$1.1K |
|
|
HMTV
2865
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $171K | ﹤0.01% |
23,476
-831
| -3% | -$8.12K |
|
|
ATHX
2866
DELISTED
Athersys, Inc. Common Stock
ATHX
| $171K | ﹤0.01% |
7,568
-141
| -2% | -$4.04K |
|
2867
Aldeyra Therapeutics
ALDX
$93.5M
| $170K | ﹤0.01% |
42,600
-853
| -2% | -$6.51K |
|
|
CLPR
2868
Clipper Realty
CLPR
$46.2M
| $169K | ﹤0.01% |
17,034
+2,314
| +16% | +$20.7K |
|
2869
Byrna Technologies
BYRN
$101M
| $168K | ﹤0.01% |
12,557
-324
| -3% | -$5.28K |
|
2870
Cytosorbents Corp
CTSO
$22.6M
| $168K | ﹤0.01% |
40,192
-660
| -2% | -$3.7K |
|
|
INFI
2871
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $168K | ﹤0.01% |
74,822
-1,006
| -1% | -$2.52K |
|
|
HGEN
2872
DELISTED
HUMANIGEN, INC.
HGEN
| $167K | ﹤0.01% |
45,007
-796
| -2% | -$4.66K |
|
2873
Invivyd
IVVD
$218M
| $166K | ﹤0.01% |
22,856
+230
| +1% | +$5.98K |
|
2874
Black Diamond Therapeutics
BDTX
$112M
| $164K | ﹤0.01% |
30,813
-580
| -2% | -$4.05K |
|
|
LOTZ
2875
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
| $164K | ﹤0.01% |
72,405
+13,097
| +22% | +$42.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2021 Portfolio in Review
As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
- RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
- RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
- RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.
Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.